Clinical Research Directory
Browse clinical research sites, groups, and studies.
Repletion of Ergothioneine in Patients With Kidney Failure
Sponsor: Stanford University
Summary
Dialysis removes potentially harmful chemicals from the blood but can also remove potentially valuable chemicals. One potentially valuable chemical called ergothioneine, which comes from the diet, is low in the blood of people receiving dialysis. For this research study, the investigators hope to learn how well a daily ergothioneine supplement will replenish the levels in the blood of people with kidney failure.
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
28
Start Date
2025-04-01
Completion Date
2030-12
Last Updated
2026-04-01
Healthy Volunteers
No
Conditions
Interventions
Ergothioneine
Participants will receive ergothioneine capsule daily for 12 weeks.
Placebo
Participants will receive placebo capsule daily for 12 weeks.
Locations (1)
Veterans Affairs Palo Alto
Palo Alto, California, United States